bpc-157 human studies review Regeneration or Risk? A Narrative of for Musculoskeletal Healing bpc-157 safety human studies review

If you have a shoulder issue that needs to be evaluated, please give us a call at 310-534-1900 or email us at [email protected]

3, 2023, Constantine GD, Archer DF, Graham S, Bernick BA, Mirkin S

Applying the products stated 5:1:1 ratio to each 2,330 mcg dose implies roughly 1.67 mg GHK-Cu + 0.33 mg TB-500 + 0.33 mg BPC-157 per injection

Relative Contraindications Active or recent malignancy Pregnancy or breastfeeding (no safety data) Active systemic infection Uncontrolled autoimmune disease in acute flare Concurrent use of anticoagulants without physician oversight Regulatory Status and Where to Source BPC-157 FDA Status (as of 2025) BPC-157 is not FDA-approved for any human therapeutic indication